Previous 10 | Next 10 |
2023-12-01 08:25:56 ET Losers: Smart for Life ( SMFL ) -38% announces exercise of warrants for $1.5 Million gross proceeds . Ampio Pharmaceuticals ( AMPE ) -34% . Incannex Healthcare ( IXHL ) -34% . Vivos Therapeutics ( VVOS ) -14% . ...
2023-11-30 08:40:55 ET Losers: Vivos Therapeutics ( VVOS ) -34% . Redhill Biopharma Ltd. ( RDHL ) -26% . Yoshiharu Global Co ( YOSH ) -25% . XORTX Therapeutics XRTX -18% announces $3.70M US ATM offering . Pure Storage PSTG -15% after...
2023-11-29 10:00:03 ET More on Health Care Select Sector SPDR Ideal Pairs Trade Into 2024: Health Vs. Hype: Capitalizing On A Therapeutic Turn And A Tech Tumble Health Care Select Sector Fund ETF: Riding The Healthcare Boom Stocks to watch in the Health Care sector a...
2023-11-29 08:23:49 ET Losers: Seelos Therapeutics ( SEEL ) -43% on pricing of $5.55 million stock offering . Leslies ( LESL ) -20% after Q4 earnings release . Farfetch Ltd ( FTCH ) -16% . ESGL Holdings Ltd ( ESGL ) -15% . Petco ...
IceCure's ProSense® Deepens Regulatory Approval in India PR Newswire ProSense® is already marketed and sold in India based on previous regulatory requirements and now has been re-classified due to new regulations Breast cancer cryoablation is alre...
2023-11-28 12:33:30 ET DENVER, Colo., Nov. 28, 2023 ( www.247marketnews.com )- The following companies published announcements or are trading higher on higher-than-usual midday volume; Icecure Medical Ltd (NASDAQ: ICCM), Avidity Biosciences Inc (NASDAQ: RNA), ESGL Holdings Ltd (NASDAQ: ...
2023-11-28 09:39:12 ET More on IceCure Medical IceCure Medical Ltd (ICCM) Q3 2023 Earnings Call Transcript IceCure stock climbs 10% amid FDA appeal, earnings report IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M Seeking Alpha’s Quant Rating on I...
IceCure System Successfully Treated Kidney Cancer Tumor with 92% Disease-Free Survival Rate and 100% Secondary Local Control Rate PR Newswire Independent study concluded: - IceCure system offers significant advantage in ability to re-treat tumors that are initial...
2023-11-15 14:56:03 ET IceCure Medical Ltd. (ICCM) Q3 2023 Earnings Conference Call November 15, 2023, 10:00 AM ET Company Participants Michael Polyviou - EVC Group, Investor Relations Eyal Shamir - Chief Executive Officer Ronen Tsimerman - Chief Financial Office...
2023-11-15 11:05:05 ET More on IceCure Medical IceCure Medical 9M GAAP EPS of -$0.26, revenue of $2M IceCure stock soars 85% in pre-market trading on positive study results Seeking Alpha’s Quant Rating on IceCure Medical Historical earnings data for Ic...
News, Short Squeeze, Breakout and More Instantly...
99.74% Recurrence Free Rate for Women with Breast Cancer Treated with IceCure's ProSense® Cryoablation System: Key Findings Delivered at 32nd Annual Meeting of the Japanese Breast Cancer Society PR Newswire Demand for minimally invasive breast cancer treatment was ove...
European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment for Metastatic and Recurrent Breast Cancer European Study Provides More Evidence Supporting IceCure's ProSense® is Safe & Effective Cryoablation Treatment fo...
U.S. Food and Drug Administration Grants Regulatory Clearance to IceCure for Next-Gen XSense™ Cryoablation System with CryoProbes PR Newswire CAESAREA, Israel , July 1, 2024 /PRNewswire/ -- IceCure Medical Ltd. (NASDAQ: ICCM) ("IceCure", "IceCure Medic...